Literature DB >> 8855264

Activation domain-mediated enhancement of activator binding to chromatin in mammalian cells.

C A Bunker1, R E Kingston.   

Abstract

DNA binding by transcriptional activators is typically an obligatory step in the activation of gene expression. Activator binding and subsequent steps in transcription are repressed by genomic chromatin. Studies in vitro have suggested that overcoming this repression is an important function of some activation domains. Here we provide quantitative in vivo evidence that the activation domain of GAL4-VP16 can increase the affinity of GAL4 for its binding site on genomic DNA in mammalian cells. Moreover, the VP16 activation domain has a much greater stimulatory effect on expression from a genomic reporter gene than on a transiently transfected reporter gene, where factor binding is more permissive. We found that not all activation domains showed a greater activation potential in a genomic context, suggesting that only some activation domains can function in vivo to alleviate the repressive effects of chromatin. These data demonstrate the importance of activation domains in relieving chromatin-mediated repression in vivo and suggest that one way they function is to increase binding of the activator itself.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855264      PMCID: PMC38239          DOI: 10.1073/pnas.93.20.10820

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Role of nucleosomal cores and histone H1 in regulation of transcription by RNA polymerase II.

Authors:  P J Laybourn; J T Kadonaga
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

2.  Activation domains of stably bound GAL4 derivatives alleviate repression of promoters by nucleosomes.

Authors:  J L Workman; I C Taylor; R E Kingston
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

3.  In situ nucleoprotein structure at the SV40 major late promoter: melted and wrapped DNA flank the start site.

Authors:  L Zhang; J D Gralla
Journal:  Genes Dev       Date:  1989-11       Impact factor: 11.361

4.  An amino-terminal fragment of GAL4 binds DNA as a dimer.

Authors:  M Carey; H Kakidani; J Leatherwood; F Mostashari; M Ptashne
Journal:  J Mol Biol       Date:  1989-10-05       Impact factor: 5.469

5.  Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit.

Authors:  E Giniger; M Ptashne
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

6.  Facilitated binding of GAL4 and heat shock factor to nucleosomal templates: differential function of DNA-binding domains.

Authors:  I C Taylor; J L Workman; T J Schuetz; R E Kingston
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

7.  Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo.

Authors:  M G Cordingley; A T Riegel; G L Hager
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

8.  Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter.

Authors:  B Piña; U Brüggemeier; M Beato
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

9.  Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter.

Authors:  T K Archer; M G Cordingley; R G Wolford; G L Hager
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

10.  Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome.

Authors:  T Perlmann; O Wrange
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  13 in total

1.  A general strategy to enhance the potency of chimeric transcriptional activators.

Authors:  S Natesan; E Molinari; V M Rivera; R J Rickles; M Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  GCN5 dependence of chromatin remodeling and transcriptional activation by the GAL4 and VP16 activation domains in budding yeast.

Authors:  G A Stafford; R H Morse
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Regions of GAL4 critical for binding to a promoter in vivo revealed by a visual DNA-binding analysis.

Authors:  Akiko Mizutani; Masafumi Tanaka
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

4.  Single-molecule and population probing of chromatin structure using DNA methyltransferases.

Authors:  Jessica A Kilgore; Scott A Hoose; Tanya L Gustafson; Weston Porter; Michael P Kladde
Journal:  Methods       Date:  2007-03       Impact factor: 3.608

5.  Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes.

Authors:  K Ikeda; D J Steger; A Eberharter; J L Workman
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

6.  SWI-SNF complex participation in transcriptional activation at a step subsequent to activator binding.

Authors:  M P Ryan; R Jones; R H Morse
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  Gal4p-mediated chromatin remodeling depends on binding site position in nucleosomes but does not require DNA replication.

Authors:  M Xu; R T Simpson; M P Kladde
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

8.  Chromatin opening and transactivator potentiation by RAP1 in Saccharomyces cerevisiae.

Authors:  L Yu; R H Morse
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

9.  Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.

Authors:  A Nishimura; T Ono; A Ishimoto; J J Dowhanick; M A Frizzell; P M Howley; H Sakai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons.

Authors:  Tracy Terry-Allison; Colton A Smith; Neal A DeLuca
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.